| Jul 9, 2014
| 6:59 AM
AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his company's takeover bid for Shire Plc.
The North Chicago-based pharmaceutical...
| Jul 11, 2014
| 2:06 PM
Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases.
Shire, in a release, said it would provide a further update "when appropriate." It...
| Jul 14, 2014
| 7:49 AM
Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion.
The deal, which will give Abbott a roughly...
| Jun 30, 2014
| 12:30 PM
MannKind Corp. shares were surging on the first full day of trading since the Food and Drug Administration approved the Valencia company’s inhaled insulin treatment for people with diabetes.
Late Friday, the FDA announced that it had approved...
| Jun 27, 2014
| 2:18 PM
Los Angeles billionaire-inventor Alfred Mann's almost decade-long quest to develop an inhalable form of insulin for diabetics won approval Friday from U.S. regulators.
His company, MannKind Corp. of Valencia, got the OK on Friday to sell the drug called...
| Jul 16, 2014
| 11:49 AM
AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way...
| Jul 18, 2014
While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon.
The Deerfield-based health...
| Jul 17, 2014
| 6:55 AM
AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes.
The deal will allow North Chicago-based pharmaceutical...
| Jul 18, 2014
| 8:20 AM
AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning.
The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
| Jul 18, 2014
| 4:51 PM
A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings.
Illinois drug maker AbbVie Inc. said Friday that it...
| Apr 14, 2014
| 7:46 PM
Charles F. Farthing, a physician who was at the forefront of care for HIV/AIDS patients and who drew attention to the need for an AIDS vaccine by announcing his willingness to inject himself, has died. He was 60.
Farthing, who collapsed in a Hong Kong...